SCHEMBL9348253

SCHEMBL9348253

Cc1ccc(N2C(=O)C3(CCCC3)C(=O)c3cccnc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
EGLN1 Q9GZT9 3/20 0.41
PGR P06401 5/20 0.41
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
TLR9 Q9NR96 1/20 0.36
ALDH1A1 P00352 2/20 0.36
ACHE P22303 1/20 0.36
ELANE P08246 1/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
AGTR1 P30556 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348254 0.88 PGR (0.43) EGLN1PGRMEN1KMT2AALDH1A1
SCHEMBL9348228 0.88 PGR (0.55) EGLN1PGRMEN1KMT2AACHE
SCHEMBL9348086 0.82 PGR (0.44) POLBPGRGAAALDH1A1NPC1
SCHEMBL9352368 0.81 PGR (0.42) POLBPGRMEN1GAAKMT2A
SCHEMBL9348232 0.80 MGLL (0.42) MEN1GAAKMT2AALDH1A1NPC1
SCHEMBL9348203 0.80 NPC1 (0.40) POLBPGRMEN1KMT2ATLR9
SCHEMBL9981596 0.70 PGR (0.57) POLBEGLN1PGRALDH1A1ELANE
SCHEMBL9537511 0.70 PGR (0.41) PGRMEN1GAAKMT2AALDH1A1
SCHEMBL9629039 0.70 EGLN1 (0.34) EGLN1PGRMEN1GAAKMT2A
SCHEMBL9628874 0.68 EGLN1 (0.36) EGLN1PGRMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0338010-B1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HYPERPROLIFERATE SKIN DISEASE SCHERING CORPORATION (US) 1992-02-05 EP claimed
EP-0228416-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZANAPHTHALENES SCHERING CORPORATION (US) 1990-03-21 EP claimed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP claimed
EP-0338010-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HYPERPROLIFERATE SKIN DISEASE. SCHERING CORP (US) 1989-10-25 EP claimed
WO-1988004172-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HYPERPROLIFERATE SKIN DISEASE SCHERING CORPORATION (US) 1988-06-16 WO claimed
EP-0228416-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZANAPHTHALENES. SCHERING CORP (US) 1987-07-15 EP claimed
WO-1986007537-A2 PHARMACEUTICAL COMPOSITIONS CONTAINING AZANAPHTHALENES SCHERING CORPORATION (US) 1986-12-31 WO claimed
EP-0144996-A2 Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-06-19 EP claimed
US-5350755-A Treatment of psoriasis or eczema with naphthyridine derivative SCHERING CORPORATION (US) 1994-09-27 US disclosed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP disclosed
US-4652564-A Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents SCHERING CORPORATION (US) 1987-03-24 US disclosed
EP-0144996-A2 Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-06-19 EP disclosed